Tests early valve replacement in people with severe aortic stenosis but no symptoms
Compares early aortic valve replacement with regular monitoring in adults with severe, symptom-free aortic stenosis.
Key facts
- Who runs it
- University of Leicester
- Where
- Aberdeen, Aintree, Ashington, Ayr, Barnsley, Basildon, Basingstoke, Birmingham, Blackpool, Bodelwyddan, Brighton, Carlisle, Chesterfield, Coventry, Darlington, Doncaster, Dorchester, Dudley, Dundee, Durham, Edinburgh, Exeter, Gateshead, Glasgow, Gloucester, High Wycombe, Huddersfield, Inverness, Isleworth, Keighley, Kettering, Kilmarnock, Leeds, Leicester, Lincoln, Liverpool, London, Maidstone, Manchester, Middlesbrough, Newcastle upon Tyne, Norwich, Nottingham, Nuneaton, Paisley, Plymouth, Poole, Portsmouth, Scunthorpe, Sheffield, Southampton, Stirling, Stockport, Stockton-on-Tees, Sunderland, Swansea, Taunton, Torquay, Truro, Wakefield, Walsall, Warwick, Watford, West Bromwich, Wolverhampton, Worcester, and Yeovil, United KingdomSee the 78 sitesAlso in 6 other countries, 31 sites
- Trial code
- Registry title
- The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
- Status
- Recruiting
- People taking part
- 2,104 people, planned
- Started
- 10 Mar 2020
- Expected to end
- 1 Apr 2031
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Aortic valve replacement
- Record updated
- 21 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe aortic stenosis (a narrowed heart valve) who have no symptoms. It compares early valve replacement with regular check-ups.
- Age
- Over 18 years.
- Sex
- All sexes can join.
- Disease stage
- Severe aortic stenosis without symptoms, shown by heart ultrasound measurements (peak velocity, pressure gradient, valve area) and, in some cases, a high calcium score.
- Earlier treatment
- No earlier aortic valve replacement (surgery or TAVI) with re-narrowing of the valve.
- Biomarker or test result
- Valve measurements: peak velocity ≥4m/s or mean pressure gradient ≥40mmHg, with a small valve area. Some people join with 3.5m/s - 3.9m/s plus a high calcium score (>1200 for females, >2000 for males).
Main reasons for not taking part
- Symptoms caused by the aortic stenosis
- Another severe heart valve disease
- Other heart surgery planned before randomisation (for example CABG)
- Weak heart pumping function (LVEF <50%)
- Pregnancy
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age >18 years
- Patient has severe asymptomatic AS, in line with current international guidelines, defined as either:; Peak velocity ≥4m/s OR mean pressure gradient ≥40mmHg WITH aortic valve area ≤1.0cm2 OR ≤0.6cm2/m2 body surface area OR; Peak velocity ≥4m/s OR mean pressure gradient ≥40mmHg WITH aortic valve area >1.0 - ≤1.2cm2 OR >0.6 - ≤0.7cm2/m2 body surface area AND high sex specific calcium score* OR; Peak Velocity ≥3.5m/s - 3.9m/s AND mean pressure gradient <40 mmHg WITH aortic valve area ≤1.0cm2 OR ≤0.6cm2/m2 body surface area AND high sex specific calcium score* *Sex specific high calcium scores (Agatston units): >1200 females; >2000 males
- The responsible clinician feels that either ongoing surveillance or early AVR are appropriate
- Regarded by the treating cardiologist to be suitable for AVR (surgical or TAVI) with an acceptable risk
- Willing to provide informed consent and be randomised to early AVR or expectant management
- An ability to understand one of the written languages that the study has provided written and visual materials in, or the availability of a translator to explain the study documentation
Who cannot take part
- Patient has previously undergone AVR or TAVI with restenosis
- Additional severe valvular heart disease
- Other cardiac surgery planned pre-randomisation (eg CABG)
- Left ventricular systolic dysfunction (LVEF <50%)
- Co-morbid condition that, in the opinion of the treating cardiologist, limits life expectancy to <2 years
- Symptoms related to AS
- Pregnancy
Where in United Kingdom
Also in 6 other countries, 31 sites
- Aberdeen Royal InfirmaryAberdeen, United KingdomContact: Dr Ciprian DospinescuTaking people
- Aintree University HospitalAintree, United KingdomContact: Dr Prathap KanagalaTaking people
- Wansbeck General HospitalAshington, United KingdomContact: Dr David RipleyTaking people
- University Hospital AyrAyr, United KingdomContact: Dr Jim McGowanTaking people
- Barnsley Hospital NHS Foundation TrustBarnsley, United KingdomContact: Deoraj ZamfarTaking people
- Basildon University HospitalBasildon, United KingdomContact: Dr Jason DunguTaking people
- Basingstoke and North Hampshire HospitalBasingstoke, United KingdomContact: Dr Jason GloverTaking people
- Queen Elizabeth HospitalBirmingham, United KingdomContact: Professor Rick SteedsTaking people
- Blackpool Victoria HospitalBlackpool, United KingdomContact: Professor Nidal BittarTaking people
- Glan Clwyd HospitalBodelwyddan, United KingdomContact: Satheesh NairTaking people
- Royal Sussex County HospitalBrighton, United KingdomContact: Dr David Hildick-SmithTaking people
- North Cumbria Integrated CareCarlisle, United KingdomContact: Dr Rhidian SheltonTaking people
- Chesterfield Royal HospitalChesterfield, United KingdomContact: Dr Justin CookeTaking people
- University Hospital Coventry & WarwickshireCoventry, United KingdomContact: Dr Luke TappTaking people
- County Durham and Darlington NHS Foundation TrustDarlington, United KingdomContact: Dr Darragh TwomeyTaking people
- Doncaster Royal InfirmaryDoncaster, United KingdomContact: Dr Gillian PayneTaking people
- Dorset County HospitalDorchester, United KingdomContact: Carla RichardsonNo longer taking part
- Russells Hall HospitalDudley, United KingdomContact: Craig BarrTaking people
- Ninewells HospitalDundee, United KingdomContact: Chim LangTaking people
- University Hospital of North DurhamDurham, United KingdomContact: Darragh TwomeyTaking people
- The Royal Infirmary of EdinburghEdinburgh, United KingdomContact: Professor Marc DweckTaking people
- Royal Devon & Exeter HospitalExeter, United KingdomContact: Dr Andrew LudmanTaking people
- Gateshead Health NHS Foundation TrustGateshead, United KingdomContact: Dr Ashfaq MohammedTaking people
- Glasgow Royal InfirmaryGlasgow, United KingdomContact: Dr Stuart WatkinsTaking people
- Golden Jubilee National HospitalGlasgow, United KingdomContact: Dr Nawwar Al-AttarTaking people
- Queen Elizabeth University HospitalGlasgow, United KingdomContact: Fraser GrahamTaking people
- Gloucestershire Hospitals NHS FoundationGloucester, United KingdomContact: Val NikolaidouTaking people
- Wycombe HospitalHigh Wycombe, United KingdomContact: Dr Piers CliffordTaking people
- Huddersfield Royal InfirmaryHuddersfield, United KingdomContact: Dr Hossam El MahyTaking people
- Raigmore HospitalInverness, United KingdomContact: Stephen LeslieTaking people
- West Middlesex University HospitalIsleworth, United KingdomContact: Dr Gajen Sunthar KanaganayagamTaking people
- Airedale General HospitalKeighley, United KingdomContact: Dr Haqeel JamilTaking people
- Kettering General HospitalKettering, United KingdomContact: Dr Kai HogrefeTaking people
- University Hospital CrosshouseKilmarnock, United KingdomContact: Dr Angie GhattasTaking people
- Leeds General InfirmaryLeeds, United KingdomContact: Professor John GreenwoodTaking people
- University Hospitals Leicester, GlenfieldLeicester, United KingdomContact: Dr Anvesha SinghTaking people
- Lincoln County HospitalLincoln, United KingdomContact: Dr Kelvin LeeTaking people
- Liverpool Heart and Chest HospitalLiverpool, United KingdomContact: Dr Timothy FairbairnTaking people
- Royal Liverpool HospitalLiverpool, United KingdomContact: Prathap KanagalaTaking people
- Chelsea And Westminster HospitalLondon, United KingdomContact: Dr Gajen Sunthar KanaganayagamTaking people
- Cleveland Clinic London HospitalLondon, United KingdomContact: Dr Guy LlyodTaking people
- Imperial College Healthcare NHS TrustLondon, United KingdomContact: Professor Jamil MayetTaking people
- St Thomas HospitalLondon, United KingdomContact: Professor Ronak RajaniTaking people
- St. Bartholomew's HospitalLondon, United KingdomContact: Dr Thomas TreibelTaking people
- St. George's HospitalLondon, United KingdomContact: Dr Sami FirooziTaking people
- University Hospital LewishamLondon, United KingdomContact: Dr Amar SinghTaking people
- Maidstone & Tunbridge Wells HospitalMaidstone, United KingdomContact: Dr Timothy WilliamsTaking people
- North Manchester General HospitalManchester, United KingdomContact: Dr Laura DobsonTaking people
- Wythenshawe HospitalManchester, United KingdomContact: Dr Laura DobsonTaking people
- The James Cook University HospitalMiddlesbrough, United KingdomContact: Dr Jeet ThambyrajahTaking people
- Freeman HospitalNewcastle upon Tyne, United KingdomContact: Professor Vijay KunadianTaking people
- Norfolk and Norwich University HospitalNorwich, United KingdomContact: Dr Vassilios VassiliouTaking people
- Kings Mill HospitalNottingham, United KingdomContact: Dr Thandar AyeTaking people
- Queens Medical CentreNottingham, United KingdomContact: Dr Michael SosinTaking people
- George Eliot HospitalNuneaton, United KingdomContact: Suresh KrishnamoorthyTaking people
- Royal Alexandra HospitalPaisley, United KingdomContact: Dr Stuart HoodTaking people
- Derriford HospitalPlymouth, United KingdomContact: Dr Sivasankar SangarajuTaking people
- Poole HospitalPoole, United KingdomContact: Dr Chris SteadmanTaking people
- Queen Alexandra HospitalPortsmouth, United KingdomContact: Dr Peter HaworthTaking people
- Scunthorpe General HospitalScunthorpe, United KingdomContact: Rashed HossainTaking people
- Northern General HospitalSheffield, United KingdomContact: Dr Muhhammad Aetesam-ur-RahmanTaking people
- Southampton General HospitalSouthampton, United KingdomContact: Professor Nick CurzenTaking people
- Forth Valley Royal HospitalStirling, United KingdomContact: Dr Christopher GinglesTaking people
- Stepping Hill HospitalStockport, United KingdomContact: Dr Rosica PanayotovaTaking people
- North Tees and Hartlepool NHS Foundation TrustStockton-on-Tees, United KingdomContact: Dr Paul DavisonTaking people
- South Tyneside and Sunderland NHS Foundation TrustSunderland, United KingdomContact: Samuel McClureTaking people
- Morriston HospitalSwansea, United KingdomContact: Alexander ChaseTaking people
- Musgrove Park HospitalTaunton, United KingdomContact: Thomas ReesTaking people
- Torbay HospitalTorquay, United KingdomContact: Dr Usman SheikhTaking people
- Royal Cornwall HospitalTruro, United KingdomContact: Dr Mohammed AbubakrTaking people
- Pinderfields HospitalWakefield, United KingdomContact: Dr Thomas CravenTaking people
- Walsall Manor HospitalWalsall, United KingdomContact: Rumi JaumdallyTaking people
- South Warwickshire University NHS Foundation TrustWarwick, United KingdomContact: Dr John FryearsonTaking people
- Watford General HospitalWatford, United KingdomContact: Dr Piyush JainTaking people
- Sandwell General HospitalWest Bromwich, United KingdomContact: Abdul MaherTaking people
- New Cross HospitalWolverhampton, United KingdomContact: Sandeep HothiTaking people
- Worcester Acute Hospitals NHS FTWorcester, United KingdomContact: Ashiq SaffyTaking people
- Yeovil District HospitalYeovil, United KingdomContact: Carla RichardsonNo longer taking part
About the trial
What the trial wants to find out
Aortic stenosis (AS) affects approximately 5% of individuals >65 years old, with ~3% of people >75 years having moderate to severe disease. The prevalence of AS is rising rapidly due to an ageing population and is projected to double in the next two decades. Increasingly clinicians face the dilemma of how to best manage this growing population of mainly elderly patients, many of whom are asymptomatic but have been identified as having severe AS, often as an incidental finding. Reduced aortic valve opening progresses over decades without any apparent symptoms because the heart compensates for the AS. Ultimately, compensatory mechanisms fail resulting in angina, syncope or heart failure. If these symptomatic patients with severe AS remain untreated, they have a dire prognosis. In this situation the only effective treatment is AVR, either surgically or using TAVI. Conversely, conventional teaching and clinical practice in cardiology has been that, in the absence of symptoms, the prognosis is usually excellent and, except in a few very specific circumstances, conservative management and regular review (expectant management) is recommended. This advice is reflected in current international guidelines but is based largely on historical precedent. There has never been a randomised controlled trial to address the relative benefits of early AVR versus expectant management in patients with severe asymptomatic AS. The relative benefits of a strategy of early AVR/TAVI versus expectant management in patients with asymptomatic severe AS are unclear. There is clinical equipoise but it remains one of the few areas of cardiovascular medicine where no randomised controlled trials (RCT) have been performed. The EASY-AS study will provide crucial data on the relative merits of these differing approaches to management, in terms of important patient orientated outcomes, conventional cardiovascular end-points and cost effectiveness.
The 2 groups in the trial
- Group A: Aortic valve replacementExisting treatment, for comparison
Participants randomised to AVR will be investigated and managed according to local protocols and standard practice. Participants will be placed on the waiting list with the aim that surgery will be performed within 6 months, dependent on local hospitals' waiting lists.
Treatment: Aortic valve replacement
- Group B: Expectant managementNo study treatment, for comparison
Participants randomised to expectant management will continue to have regular monitoring of their condition in line with the procedures and standard practices of their hospital.
Results explained
A paper that names this trial, explained in plain words.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Randomised Controlled Trial of Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis
- Plain-language title
- Tests early valve replacement in people with severe aortic stenosis but no symptomsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Factors influencing the decision to accept or decline aortic valve replacement for asymptomatic aortic stenosis: a nested longitudinal qualitative substudy of the EASY-AS randomised trial.BMJ open, 2026
- Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial.American heart journal, 2024
- Record updated
- 21 July 2026